Your browser doesn't support javascript.
loading
Cost-Effectiveness Analysis of Rivaroxaban in Chinese Patients With Stable Cardiovascular Disease.
Feng, Tianyu; Zheng, Zhou; Gao, Shang; Xu, Jiaying; Cao, Pen; Jia, Huanhuan; Yu, Xihe.
Afiliação
  • Feng T; School of Public Health, Jilin University, Changchun, China.
  • Zheng Z; School of Public Health, Jilin University, Changchun, China.
  • Gao S; School of Public Health, Jilin University, Changchun, China.
  • Xu J; School of Public Health, Jilin University, Changchun, China.
  • Cao P; School of Public Health, Jilin University, Changchun, China.
  • Jia H; School of Public Health, Jilin University, Changchun, China.
  • Yu X; School of Public Health, Jilin University, Changchun, China.
Front Pharmacol ; 13: 921387, 2022.
Article em En | MEDLINE | ID: mdl-35795549

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Ano de publicação: 2022 Tipo de documento: Article